Related Experiment Video
Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Clinical Manifestations
Beili Shao1,2, Abigail Rebecca Lee2, Elizabeta Mukaetova-Ladinska3
1School of Medicine, University of Nottingham, Nottingham, Nottinghamshire, United Kingdom.
This study highlights the diverse causes of mild cognitive impairment (MCI) in young-onset dementia clinics, emphasizing the importance of accurate diagnosis for effective treatment. Alzheimer's disease was the most frequent diagnosis among participants.
Area of Science:
- Neurology
- Neuroscience
- Gerontology
Background:
- Mild cognitive impairment (MCI) represents a critical transitional phase between normal aging and dementia, posing diagnostic challenges due to its varied origins and progression.
- Accurate early diagnosis and subtyping of MCI are essential for implementing targeted therapies and providing adequate patient and family support.
Purpose of the Study:
- To investigate the heterogeneous causes and co-pathologies of mild cognitive impairment (MCI) in individuals referred to a regional tertiary memory clinic specializing in young-onset dementia.
- To analyze demographic, clinical, cognitive, cerebrospinal fluid (CSF) biomarker, and neuroimaging data from a prospective longitudinal cohort.
Main Methods:
- A six-year observational study (December 2018 - November 2024) at Queen's Medical Centre, Nottingham, involving patients referred to the Young-Onset Dementia Clinic.
- Data collection included demographic, clinical assessments, cognitive testing (ACE-III), CSF biomarkers, and neuroimaging (MRI, FDG-PET) as part of the Cognition and NeuroImaging in Neurodegenerative Disorders (CogNID) study.
- Analysis of 429 participants (68.10% of 630 referrals) with a mean age of 60.08 years.
Main Results:
- Alzheimer's disease (AD) was the most common diagnosis (24.94%), followed by functional cognitive decline (12.59%), frontotemporal dementia (6.99%), and COVID-related cognitive impairment (6.06%).
- Mixed pathologies were identified in 12.82% of participants, with AD and frontotemporal dementia (FTD) being the most frequent co-occurrence.
- Participants exhibited cognitive deficits, particularly in attention, memory, and fluency, with brain MRI being the primary investigation method.
Conclusions:
- The study underscores the complex and diverse etiologies underlying MCI in the context of young-onset dementia.
- Findings emphasize the need for comprehensive diagnostic approaches, including biomarker and neuroimaging analysis, to identify co-pathologies and guide treatment strategies.
- Real-world data from memory clinics provide crucial insights into the heterogeneous nature of MCI and its management.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Endocarditis II: Clinical Features of Infective Endocarditis
Heart Failure III: Clinical Manifestations
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Hypertension III: Clinical Manifestations and Diagnostic Studies

